Goldman Sachs’s Quipt Home Medical QIPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-481,791
| Closed | -$1.7M | – | 6889 |
|
|
2025
Q4 | $1.7M | Buy |
481,791
+367,143
| +320% | +$972K | ﹤0.01% | 4732 |
|
|
2025
Q3 | $299K | Sell |
114,648
-136,840
| -54% | -$316K | ﹤0.01% | 5753 |
|
|
2025
Q2 | $450K | Buy |
251,488
+78,451
| +45% | +$155K | ﹤0.01% | 5221 |
|
|
2025
Q1 | $403K | Sell |
173,037
-58,190
| -25% | -$159K | ﹤0.01% | 5318 |
|
|
2024
Q4 | $705K | Buy |
231,227
+55,855
| +32% | +$150K | ﹤0.01% | 5048 |
|
|
2024
Q3 | $512K | Buy |
175,372
+70,870
| +68% | +$219K | ﹤0.01% | 5038 |
|
|
2024
Q2 | $336K | Buy |
104,502
+17,896
| +21% | +$64.2K | ﹤0.01% | 5037 |
|
|
2024
Q1 | $378K | Buy |
86,606
+27,761
| +47% | +$125K | ﹤0.01% | 4875 |
|
|
2023
Q4 | $300K | Buy |
58,845
+21,415
| +57% | +$103K | ﹤0.01% | 5006 |
|
|
2023
Q3 | $191K | Sell |
37,430
-9,993
| -21% | -$53.6K | ﹤0.01% | 5055 |
|
|
2023
Q2 | $253K | Buy |
47,423
+24,055
| +103% | +$142K | ﹤0.01% | 5094 |
|
|
2023
Q1 | $164K | Buy |
+23,368
| New | +$144K | ﹤0.01% | 5361 |
|
Goldman Sachs's QIPT Position: Q1 2026 in Review
Goldman Sachs sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 481,791 shares — an estimated $1.7M sold.
Goldman Sachs first reported a position in QIPT in Q1 2023 and held it in 12 quarters. The position peaked at $1.7M in Q4 2025. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.
- Goldman Sachs reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
- Goldman Sachs sold 481,791 Quipt Home Medical shares in Q1 2026, an estimated $1.7M.
- Goldman Sachs first reported a position in Quipt Home Medical in Q1 2023 and held it in 12 quarters.
- Goldman Sachs's Quipt Home Medical position peaked at $1.7M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.